José F. Rodríguez-Orengo to Male
This is a "connection" page, showing publications José F. Rodríguez-Orengo has written about Male.
Connection Strength
0.341
-
Mattei J, Tamez M, O'Neill J, Haneuse S, Mendoza S, Orozco J, Lopez-Cepero A, R?os-Bedoya CF, Falc?n LM, Tucker KL, Rodr?guez-Orengo JF. Chronic Diseases and Associated Risk Factors Among Adults in Puerto Rico After Hurricane Maria. JAMA Netw Open. 2022 01 04; 5(1):e2139986.
Score: 0.057
-
Mattei J, Tucker KL, Falc?n LM, R?os-Bedoya CF, Kaplan RM, O'Neill HJ, Tamez M, Mendoza S, D?az-?lvarez CB, Orozco JE, Acosta P?rez E, Rodr?guez-Orengo JF. Design and Implementation of the Puerto Rico Observational Study of Psychosocial, Environmental, and Chronic Disease Trends (PROSPECT). Am J Epidemiol. 2021 05 04; 190(5):707-717.
Score: 0.054
-
Mattei J, Tamez M, R?os-Bedoya CF, Xiao RS, Tucker KL, Rodr?guez-Orengo JF. Health conditions and lifestyle risk factors of adults living in Puerto Rico: a cross-sectional study. BMC Public Health. 2018 04 12; 18(1):491.
Score: 0.044
-
Rodr?guez-Torres M, Burguera J, Hallman D, Rodr?guez-Orengo J, Echeandia M. ?Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients. Ann Hepatol. 2012 Jul-Aug; 11(4):450-63.
Score: 0.029
-
Ram?rez-Marrero FA, Rivera-Brown AM, Nazario CM, Rodr?guez-Orengo JF, Smit E, Smith BA. Self-reported physical activity in Hispanic adults living with HIV: comparison with accelerometer and pedometer. J Assoc Nurses AIDS Care. 2008 Jul-Aug; 19(4):283-94.
Score: 0.022
-
Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Jim?nez-Rivera J. Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: a paired liver biopsy study. J Hepatol. 2007 Apr; 46(4):613-9.
Score: 0.020
-
Rodr?guez-Torres M, Rodr?guez-Orengo JF, R?os-Bedoya CF, Fern?ndez-Carbia A, Gonz?lez-Lassalle E, Salgado-Mercado R, Marxuach-Cu?tara AM. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy. J Clin Virol. 2007 Jan; 38(1):32-8.
Score: 0.020
-
Rodr?guez-Torres M, R?os-Bedoya CF, Rodr?guez-Orengo J, Fern?ndez-Carbia A, Marxuach-Cu?tara AM, L?pez-Torres A, Salgado-Mercado R, Br?u N. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender. J Clin Gastroenterol. 2006 Apr; 40(4):358-66.
Score: 0.019
-
Br?u N, Salvatore M, R?os-Bedoya CF, Fern?ndez-Carbia A, Paronetto F, Rodr?guez-Orengo JF, Rodr?guez-Torres M. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol. 2006 Jan; 44(1):47-55.
Score: 0.018
-
Rodr?guez-Torres M, Salgado-Mercado R, R?os-Bedoya CF, Aponte-Rivera E, Marxuach-Cu?tara AM, Rodr?guez-Orengo JF, Fern?ndez-Carbia A. High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci. 2005 Apr; 50(4):634-9.
Score: 0.018
-
Mattei J, Tamez M, Bigornia SJ, Noel SE, Xiao RS, R?os-Bedoya CF, Rodr?guez-Orengo JF, Tucker KL. Dietary Intake and Its Determinants Among Adults Living in the Metropolitan Area of Puerto Rico. Nutrients. 2019 Jul 14; 11(7).
Score: 0.012
-
Tamez M, R?os-Bedoya CF, Rodr?guez-Orengo JF, Tucker KL, Mattei J. Sociodemographic and Lifestyle Factors, and Health Conditions of Dominican Adults Living in Puerto Rico. J Immigr Minor Health. 2018 Oct; 20(5):1085-1093.
Score: 0.011
-
Preston AM, Rodr?guez-Orengo J, Gonz?lez-Sep?lveda L, Ayala-Pe?a S, Maldonado-Maldonado E. Effect of Housing Type on 25 OH Vitamin D in Serum of Rhesus Monkeys. P R Health Sci J. 2018 06; 37(2):124-127.
Score: 0.011
-
Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodr?guez E, Plaud-Valent?n M, Rodr?guez-Orengo J, Gendelman HE, Mel?ndez LM. CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol. 2007 Dec; 192(1-2):157-70.
Score: 0.005